E. Lopci and M. Meignan, Deauville score: the Phoenix rising from ashes, Eur J Nucl Med Mol Imaging, 2018.
DOI : 10.1007/s00259-018-4215-9
URL : https://hal.archives-ouvertes.fr/hal-02068185

N. Aide, R. J. Hicks, C. L. Tourneau, S. Lheureux, S. Fanti et al., FDG PET/CT for assessing tumour response to immunotherapy, European journal of nuclear medicine and molecular imaging, pp.1-13, 2019.
DOI : 10.1007/s00259-018-4171-4
URL : https://hal.archives-ouvertes.fr/inserm-02101049

L. Dercle, S. Ammari, R. D. Seban, L. H. Schwartz, R. Houot et al., Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma, Eur J Cancer, vol.91, pp.136-144, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01788935

L. Dercle, R. D. Seban, J. Lazarovici, L. H. Schwartz, R. Houot et al., )F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-Programmed Death 1 Immune Checkpoint Inhibitor, J Nucl Med, vol.59, issue.18, pp.15-24, 2018.

A. Mekki, L. Dercle, P. Lichtenstein, A. Marabelle, J. Michot et al., Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1, European Journal of Cancer, vol.96, pp.91-104, 2018.